Global Single Cell Analysis Market 2022-2026

Global Single Cell Analysis Market 2022-2026

Technavio has been monitoring the single cell analysis market and it is poised to grow by $ 3165.98 million during 2022-2026, progressing at a CAGR of 15.11% during the forecast period. Our report on the single cell analysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of cancer, growing R and D in the pharmaceutical and biotechnology industries, and growth in stem cell research. In addition, the increasing prevalence of cancer is anticipated to boost the growth of the market as well.

The single cell analysis market analysis includes the product segment and geographic landscape.

Technavio's single cell analysis market is segmented as below:

• By Product
• Consumables
• Instrument
• By Geographic
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising incidence of chronic diseases and genetic disorders as one of the prime reasons driving the single cell analysis market growth during the next few years. Also, the growth potential of single cell sequencing and integration of microfluidics in single cell analysis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on single cell analysis market covers the following areas:

• Single cell analysis market sizing
• Single cell analysis market forecast
• Single cell analysis market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading single cell analysis market vendors that include 10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, and Sartorius AG. Also, the single cell analysis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, Sartorius AG